With a PhD (Analytical Chemistry, 2000) from the University of Alberta, Dawn has worked in a variety of roles, however her diagnosis with rheumatoid arthritis nearly 20 years ago led her on a journey combining her passion for science and making the most of her diagnosis. She founded Five02 Labs Inc to help people and organizations design and execute their patient engagement initiatives using leading practices and tailoring their approaches to meet their goals and patient partners’ needs. She has contributed to the literature and practice in patient engagement on compensation, authorship, recognizing patients as people with skills and who lead fulfilling lives, and training on patient engagement in research. At the Brain-Heart Interconnectome, Dawn is the patient engagement lead, and she supports patient and public engagement efforts at Clinical Trials Ontario, the University Health Network, and CIHR’s Institute of Musculoskeletal Health and Arthritis. As a volunteer Dawn is Vice President of the Canadian Arthritis Patient Alliance and a member of the BMJ Patient Panel.